I am drafting an email too. I would directly send it to his personal email address. I don't expect his personal reply that could be useless as before. I am hoping he is pressurized to handle tough questions at AGM.
In past three years, our most advanced clinical trial failed. The negotiation with FDA failed too. This company cannot always ask investors to be patient. This company needs to do something right to commercialise their product...
Letter to the GK, page-4
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.001(33.3%) |
Mkt cap ! $21.28M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.4¢ | 0.3¢ | $1.247K | 384.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 39 | 52935756 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 127950526 | 19 |
View Market Depth
| Last trade - 16.10pm 14/08/2024 (20 minute delay) ? |
| ATH (ASX) Chart |